Bifunctional cleavable probes for in situ multiplexed glycan detection and imaging using mass spectrometry

por Ma, Wen, Xu, Shuting, Nie, Honggang, Hu, Bingyang, Bai, Yu, Liu, Huwei
Publicado 2018

Successful Treatment of Advanced Intrahepatic Cholangiocarcinoma With a High Tumor Mutational Burden and PD-L1 Expression by PD-1 Blockade Combined With Tyrosine Kinase Inhibitors:...

por Zhang, Ze, Zhang, Wenwen, Wang, Hongguang, Hu, Bingyang, Wang, Zhanbo, Lu, Shichun
Publicado 2021

Construction and Validation of a Ferroptosis-Related lncRNA Signature as a Novel Biomarker for Prognosis, Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma

por Zhang, Ze, Zhang, Wenwen, Wang, Yafei, Wan, Tao, Hu, Bingyang, Li, Chonghui, Ge, Xinlan, Lu, Shichun
Publicado 2022

Prognosis and Tumour Immune Microenvironment of Patients With Hepatocellular Carcinoma by a Novel Pyroptosis-Related lncRNA Signature

por Zhang, Ze, Shang, Jin, Hu, Bingyang, Shi, Huizhong, Cao, Yinbiao, Li, Junfeng, Jiao, Tianyu, Zhang, Wenwen, Lu, Shichun
Publicado 2022

Efficacy of treatment based on TKIs in combination with PD-1 inhibitors for unresectable recurrent hepatocellular carcinoma

por Zhang, Ze, Jiao, Tianyu, Li, Junfeng, Hu, Bingyang, Zhang, Wenwen, Wang, Zhijun, Wan, Tao, Wang, Yafei, Lu, Shichun
Publicado 2023

Factors influencing the prognosis patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma undergoing salvage surgery after conversion therapy

por Pan, Yingwei, Yang, Li, Cao, Yinbiao, Jun, Han, Tang, Haowen, Zhang, Wenwen, Wan, Tao, Jiao, Tianyu, Hu, Bingyang, Lu, Shichun
Publicado 2023

Two cases of intrahepatic cholangiocellular carcinoma with high insertion-deletion ratios that achieved a complete response following chemotherapy combined with PD-1 blockade

por Sui, Minghao, Li, Yu, Wang, Hongguang, Luo, Ying, Wan, Tao, Wang, Xun, Hu, Bingyang, Cheng, Yanshuang, Lv, Xianrong, Xin, Xianlei, Xu, Qiang, Wang, Guan, Lu, Shichun
Publicado 2019

Surgery After Conversion Therapy With PD-1 Inhibitors Plus Tyrosine Kinase Inhibitors Are Effective and Safe for Advanced Hepatocellular Carcinoma: A Pilot Study of Ten Patients

por Zhang, Wenwen, Hu, Bingyang, Han, Jun, Wang, Zhanbo, Ma, Guangyu, Ye, Huiyi, Yuan, Jing, Cao, Junning, Zhang, Ze, Shi, Jihang, Chen, Mingyi, Wang, Xun, Xu, Yinzhe, Cheng, Yanshuang, Tian, Lantian, Wang, Hongguang, Lu, Shichun
Publicado 2021

Lenvatinib plus anti-PD-1 antibodies as conversion therapy for patients with unresectable intermediate-advanced hepatocellular carcinoma: a single-arm, phase II trial

por Zhang, Wenwen, Tong, Shuang, Hu, Bingyang, Wan, Tao, Tang, Haowen, Zhao, Feilong, Jiao, Tianyu, Li, Junfeng, Zhang, Ze, Cai, Jinping, Ye, Huiyi, Wang, Zhanbo, Chen, Shiqing, Wang, Yafei, Li, Xuerui, Wang, Fangzhou, Cao, Junning, Tian, Lantian, Zhao, Xiaochen, Chen, Mingyi, Wang, Hongguang, Cai, Shouwang, Hu, Minggen, Bai, Yuezong, Lu, Shichun
Publicado 2023